Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Dude51on Sep 09, 2020 7:55pm
136 Views
Post# 31531074

RE:RE:RE:Any KLY news from an independent source?

RE:RE:RE:Any KLY news from an independent source?
Scotty, Scotty and Losingmyshit, when you all read the previous post about Salzman Team and the level of experience and educational back grounds for this company and you read what Andrew Salzman has done with his life and realize, glad he likes KLY deal, it's awesome. What did you guys do today? Read any books, with out pictures? I have to wonder, do you know how to read? Do you think Salzman, KLY folk are lying about their credentials and experience just so that they can scam you out of your paper route money?

Please reread Andrew Salzman's history one more time or my guess the first time. Then tell me he is a scammer. My guess you watch a lot of Fox News. There is no conspiracy to steal money yours or mine. If these folk were bullshitting about their stuff why would Barada give the Salzman group multi million dollar contracts?

Scotty and Losingmyshit, slow down when you read, push the words into your brain, repeat, repeat till you get it. Then buy more shares or in your cases by some. Choo, choo folks  the train will soon be leaving the station. Here is a news flash, "Nobody has the cure for Covid-19".

We should be going live end of month, that's the latest I have read and my guess there will be good news to go with it. R-107, that's our ticket. NO, we have the liquid, with patents, no one else does is my understanding.  So basher's tell us of some other entity that has NO in liquid form?
Just one link and no Fox links please, just one link, bet you can't do it? One link, just one.

I figured as much.
GLTA
<< Previous
Bullboard Posts
Next >>